The role of vitamin K in osteoarthritis
Main Author: | |
---|---|
Publication Date: | 2016 |
Format: | Master thesis |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | http://hdl.handle.net/10400.1/9885 |
Summary: | Osteoarthritis (OA) is the most frequent chronic rheumatic disease, affecting approximately 15% of the population, with a higher prevalence among the elderly; occurring in synovial joints such as the hips, knees and the ankle. This condition develops when the joint organ homeostasis is affected, causing abnormal remodeling of the articular tissues, leading to degradation of the cartilage, thickening of the subchondral bone, formation of osteophytes and variable degrees of inflammation. The burden of OA clinically characterized by chronic pain and significant disability is high, and only few nonpharmacologic and pharmacologic treatment options are available, mostly focused on providing symptomatic relief and showing limited efficacy and several side effects. The research on this disease in need for novel therapeutic alternatives has increased and lately is becoming fully recognized that joint’s calcification and the crosstalk with inflammation should be considered as an OA therapeutic target. In this context, vitamin K has been recognized as playing multifunctional roles that may modulate the pathogenesis of the disease. Vitamin K acts as an essential coenzyme in the post-translational modification of specific glutamic acid residues (Glu) into γ-carboxyglutamic acid residues (Gla) in target proteins, known as vitamin K-dependent proteins (VKDPs), to make them biologically active. Mineral-related Gla proteins, have been proposed as regulators of cell differentiation and inhibitors of mineralization in articular systems, so impairment in their γ-carboxylation status should have an impact in joint’s health, showing a plausible rationale for the connection of vitamin K through the OA stages. This old vitamin is now presented in a new perspective, with emerged value in human’s health, crucial in the prevention of pathological calcification and an important protective tool against inflammation and oxidative stress; revealing a promising potential as a prophylactic and therapeutic agent in OA. |
id |
RCAP_68b3f7cfed76cd5d96d709b44768247e |
---|---|
oai_identifier_str |
oai:sapientia.ualg.pt:10400.1/9885 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
The role of vitamin K in osteoarthritisOsteoartriteVitamina KProteínas GlaCalcificação patológicaInflamaçãoOsteoarthritis (OA) is the most frequent chronic rheumatic disease, affecting approximately 15% of the population, with a higher prevalence among the elderly; occurring in synovial joints such as the hips, knees and the ankle. This condition develops when the joint organ homeostasis is affected, causing abnormal remodeling of the articular tissues, leading to degradation of the cartilage, thickening of the subchondral bone, formation of osteophytes and variable degrees of inflammation. The burden of OA clinically characterized by chronic pain and significant disability is high, and only few nonpharmacologic and pharmacologic treatment options are available, mostly focused on providing symptomatic relief and showing limited efficacy and several side effects. The research on this disease in need for novel therapeutic alternatives has increased and lately is becoming fully recognized that joint’s calcification and the crosstalk with inflammation should be considered as an OA therapeutic target. In this context, vitamin K has been recognized as playing multifunctional roles that may modulate the pathogenesis of the disease. Vitamin K acts as an essential coenzyme in the post-translational modification of specific glutamic acid residues (Glu) into γ-carboxyglutamic acid residues (Gla) in target proteins, known as vitamin K-dependent proteins (VKDPs), to make them biologically active. Mineral-related Gla proteins, have been proposed as regulators of cell differentiation and inhibitors of mineralization in articular systems, so impairment in their γ-carboxylation status should have an impact in joint’s health, showing a plausible rationale for the connection of vitamin K through the OA stages. This old vitamin is now presented in a new perspective, with emerged value in human’s health, crucial in the prevention of pathological calcification and an important protective tool against inflammation and oxidative stress; revealing a promising potential as a prophylactic and therapeutic agent in OA.Simes, DinaSapientiaPereira, Carla Margarida da Silva2017-07-20T17:00:32Z2016-11-2320162016-11-23T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.1/9885urn:tid:201705370enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-18T17:38:48Zoai:sapientia.ualg.pt:10400.1/9885Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:30:15.171271Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
The role of vitamin K in osteoarthritis |
title |
The role of vitamin K in osteoarthritis |
spellingShingle |
The role of vitamin K in osteoarthritis Pereira, Carla Margarida da Silva Osteoartrite Vitamina K Proteínas Gla Calcificação patológica Inflamação |
title_short |
The role of vitamin K in osteoarthritis |
title_full |
The role of vitamin K in osteoarthritis |
title_fullStr |
The role of vitamin K in osteoarthritis |
title_full_unstemmed |
The role of vitamin K in osteoarthritis |
title_sort |
The role of vitamin K in osteoarthritis |
author |
Pereira, Carla Margarida da Silva |
author_facet |
Pereira, Carla Margarida da Silva |
author_role |
author |
dc.contributor.none.fl_str_mv |
Simes, Dina Sapientia |
dc.contributor.author.fl_str_mv |
Pereira, Carla Margarida da Silva |
dc.subject.por.fl_str_mv |
Osteoartrite Vitamina K Proteínas Gla Calcificação patológica Inflamação |
topic |
Osteoartrite Vitamina K Proteínas Gla Calcificação patológica Inflamação |
description |
Osteoarthritis (OA) is the most frequent chronic rheumatic disease, affecting approximately 15% of the population, with a higher prevalence among the elderly; occurring in synovial joints such as the hips, knees and the ankle. This condition develops when the joint organ homeostasis is affected, causing abnormal remodeling of the articular tissues, leading to degradation of the cartilage, thickening of the subchondral bone, formation of osteophytes and variable degrees of inflammation. The burden of OA clinically characterized by chronic pain and significant disability is high, and only few nonpharmacologic and pharmacologic treatment options are available, mostly focused on providing symptomatic relief and showing limited efficacy and several side effects. The research on this disease in need for novel therapeutic alternatives has increased and lately is becoming fully recognized that joint’s calcification and the crosstalk with inflammation should be considered as an OA therapeutic target. In this context, vitamin K has been recognized as playing multifunctional roles that may modulate the pathogenesis of the disease. Vitamin K acts as an essential coenzyme in the post-translational modification of specific glutamic acid residues (Glu) into γ-carboxyglutamic acid residues (Gla) in target proteins, known as vitamin K-dependent proteins (VKDPs), to make them biologically active. Mineral-related Gla proteins, have been proposed as regulators of cell differentiation and inhibitors of mineralization in articular systems, so impairment in their γ-carboxylation status should have an impact in joint’s health, showing a plausible rationale for the connection of vitamin K through the OA stages. This old vitamin is now presented in a new perspective, with emerged value in human’s health, crucial in the prevention of pathological calcification and an important protective tool against inflammation and oxidative stress; revealing a promising potential as a prophylactic and therapeutic agent in OA. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-11-23 2016 2016-11-23T00:00:00Z 2017-07-20T17:00:32Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.1/9885 urn:tid:201705370 |
url |
http://hdl.handle.net/10400.1/9885 |
identifier_str_mv |
urn:tid:201705370 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833598688867385344 |